CGRWX
Price
$33.56
Change
+$0.13 (+0.39%)
Updated
Aug 19 closing price
Net Assets
767.63M
VIVIX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

CGRWX vs VIVIX

Header iconCGRWX vs VIVIX Comparison
Open Charts CGRWX vs VIVIXBanner chart's image
Invesco Comstock Select A
Price$33.56
Change+$0.13 (+0.39%)
VolumeN/A
Net Assets767.63M
Vanguard Value Index I
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
CGRWX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGRWX vs. VIVIX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRWX is a Hold and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. CGRWX (768M). VIVIX pays higher dividends than CGRWX: VIVIX (2.19) vs CGRWX (1.52). CGRWX was incepted earlier than VIVIX: CGRWX (40 years) vs VIVIX (27 years). CGRWX (0.93) is less costly to investors than VIVIX (0.04). CGRWX is a more actively managed with annual turnover of: 70.00 vs. VIVIX (9.00). CGRWX has a lower initial minimum investment than VIVIX: CGRWX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.59 vs. CGRWX (-3.15). VIVIX return over 5 years is better than : 70.23 vs. CGRWX (52.51).
CGRWXVIVIXCGRWX / VIVIX
Total Expense Ratio0.920.042,300%
Annual Report Gross Expense Ratio0.930.042,325%
Fund Existence40 years27 years-
Gain YTD8.1916.548125%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets768M196B0%
Annual Yield % from dividends1.522.1970%
Returns for 1 year-3.157.59-42%
Returns for 3 years2.1727.048%
Returns for 5 years52.5170.2375%
Returns for 10 years25.74127.4520%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB1.240.05
+4.20%
PDS Biotechnology Corp
MASI153.930.06
+0.04%
Masimo Corp
TAVIU10.54N/A
N/A
Tavia Acquisition Corp
IMCR32.31-0.57
-1.73%
Immunocore Holdings plc
TNXP40.07-11.28
-21.97%
Tonix Pharmaceuticals Holding Corp